| Dr Beverley A Hall-ndlovu, MD | |
|
100 S 2nd St Ste 4a, Harrisburg, PA 17101-2542 | |
| (717) 231-8341 | |
| (717) 231-8705 |
| Full Name | Dr Beverley A Hall-ndlovu |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 100 S 2nd St Ste 4a, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285612515 | NPI | - | NPPES |
| 001590583 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD053976L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Health Medical Services | 7618960493 | 942 |
News Archive
Eckert & Ziegler Strahlen- und Medizintechnik AG, a company specializing in special compounds for the diagnosis and treatment of cancer, via its subsidiary company Eckert & Ziegler f-con Deutschland GmbH closed an exclusive sales agreement with the Karlsruhe-based ZAG Zyklotron AG for the regular delivery of Fluorodeoxyglucose (18F) (FDG). FDG is used in the context of the so called Positron Emission Tomography (PET) for the safe and quick recognition of even the smallest tumour foci.
CEL-SCI Corporation announced today it has received governmental approval from the Health Authority, Ministry of Health of Ukraine, to begin enrollment of subjects for a Phase III clinical trial of Multikine® in Ukraine. Multikine is the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. Ukraine is one of nine countries to participate in this global Phase III trial. The Phase III trial will be run at about 48 clinical centers, of which about 6 centers will be in Ukraine.
Gordon Alexander, director of the office of research at UNICEF's Innocenti Research Centre, writes in this post on the Guardian's "Poverty Matters Blog" that a series published in Friday's Lancet on early child development (ECD) shows "that the payoff from concerted, integrated action around ECD would be enormous."
Aptuit, Inc., and Siena Biotech S.p.A., today announced a strategic partnership in which Siena Biotech will take a minority stake in Aptuit's Italian operations in Verona, Italy, and Aptuit will become a provider of choice for Siena Biotech's development pipeline. Under the agreement Aptuit and Siena Biotech will work collaboratively on the development of Siena Biotech's pipeline of compounds, focused in three key therapeutic areas, including Alzheimer's disease, Huntington's disease and oncology.
› Verified 1 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
Eckert & Ziegler Strahlen- und Medizintechnik AG, a company specializing in special compounds for the diagnosis and treatment of cancer, via its subsidiary company Eckert & Ziegler f-con Deutschland GmbH closed an exclusive sales agreement with the Karlsruhe-based ZAG Zyklotron AG for the regular delivery of Fluorodeoxyglucose (18F) (FDG). FDG is used in the context of the so called Positron Emission Tomography (PET) for the safe and quick recognition of even the smallest tumour foci.
CEL-SCI Corporation announced today it has received governmental approval from the Health Authority, Ministry of Health of Ukraine, to begin enrollment of subjects for a Phase III clinical trial of Multikine® in Ukraine. Multikine is the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. Ukraine is one of nine countries to participate in this global Phase III trial. The Phase III trial will be run at about 48 clinical centers, of which about 6 centers will be in Ukraine.
Gordon Alexander, director of the office of research at UNICEF's Innocenti Research Centre, writes in this post on the Guardian's "Poverty Matters Blog" that a series published in Friday's Lancet on early child development (ECD) shows "that the payoff from concerted, integrated action around ECD would be enormous."
Aptuit, Inc., and Siena Biotech S.p.A., today announced a strategic partnership in which Siena Biotech will take a minority stake in Aptuit's Italian operations in Verona, Italy, and Aptuit will become a provider of choice for Siena Biotech's development pipeline. Under the agreement Aptuit and Siena Biotech will work collaboratively on the development of Siena Biotech's pipeline of compounds, focused in three key therapeutic areas, including Alzheimer's disease, Huntington's disease and oncology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Beverley A Hall-ndlovu, MD 409 S 2nd St, Suite 2f, Harrisburg, PA 17104-1612 Ph: () - | Dr Beverley A Hall-ndlovu, MD 100 S 2nd St Ste 4a, Harrisburg, PA 17101-2542 Ph: (717) 231-8341 |
News Archive
Eckert & Ziegler Strahlen- und Medizintechnik AG, a company specializing in special compounds for the diagnosis and treatment of cancer, via its subsidiary company Eckert & Ziegler f-con Deutschland GmbH closed an exclusive sales agreement with the Karlsruhe-based ZAG Zyklotron AG for the regular delivery of Fluorodeoxyglucose (18F) (FDG). FDG is used in the context of the so called Positron Emission Tomography (PET) for the safe and quick recognition of even the smallest tumour foci.
CEL-SCI Corporation announced today it has received governmental approval from the Health Authority, Ministry of Health of Ukraine, to begin enrollment of subjects for a Phase III clinical trial of Multikine® in Ukraine. Multikine is the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. Ukraine is one of nine countries to participate in this global Phase III trial. The Phase III trial will be run at about 48 clinical centers, of which about 6 centers will be in Ukraine.
Gordon Alexander, director of the office of research at UNICEF's Innocenti Research Centre, writes in this post on the Guardian's "Poverty Matters Blog" that a series published in Friday's Lancet on early child development (ECD) shows "that the payoff from concerted, integrated action around ECD would be enormous."
Aptuit, Inc., and Siena Biotech S.p.A., today announced a strategic partnership in which Siena Biotech will take a minority stake in Aptuit's Italian operations in Verona, Italy, and Aptuit will become a provider of choice for Siena Biotech's development pipeline. Under the agreement Aptuit and Siena Biotech will work collaboratively on the development of Siena Biotech's pipeline of compounds, focused in three key therapeutic areas, including Alzheimer's disease, Huntington's disease and oncology.
› Verified 1 days ago
Kenneth J Oken, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4700 Union Deposit Rd, Ste 140, Harrisburg, PA 17111 Phone: 717-652-6605 Fax: 717-652-6431 | |
Amber C O'leary, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 121 N Nyes Rd Ste C, Harrisburg, PA 17112 Phone: 717-657-4045 Fax: 717-531-0405 | |
Margaret M Hawn, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4700 Union Deposit Rd, Ste 140, Harrisburg, PA 17111 Phone: 717-652-6605 Fax: 717-652-6431 | |
Andrew Perrotti, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4700 Union Deposit Rd, Ste 140, Harrisburg, PA 17111 Phone: 717-652-6605 Fax: 717-652-6431 | |
Dr. Henry Daniel Train, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1465 Old Colonial Rd, Harrisburg, PA 17112 Phone: 717-545-8846 | |
Dr. Potacia Wynette Francis, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 110 S 17th St, Harrisburg, PA 17104 Phone: 717-232-9971 | |
Dr. William Michael Mccall, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 417 Trudy Rd, Harrisburg, PA 17109 Phone: 717-652-2537 Fax: 717-540-9252 |